Search research articles
Contact Us
Filters
Showing results (61-70 of 110) with videos related to
Page
of 11
Sort By:
Journal of Clinical Pharmacology
|
January 25, 2007
Pharmacokinetics of maribavir, a novel oral anticytomegalovirus agent, in subjects with varying degrees of renal impairment
Suzanne K Swan, William B Smith, Thomas C Marbury, et al.
Journal of Clinical Pharmacology
|
October 30, 2013
A randomized, placebo-controlled study of the pharmacokinetics, pharmacodynamics, and tolerability of the oral JAK2 inhibitor fedratinib (SAR302503) in healthy volunteers
Meng Zhang, Christine R Xu, Elias Shamiyeh, et al.
The Journal of Organic Chemistry
|
March 25, 2005
Photorearrangement of alpha-azoxy ketones and triplet sensitization of azoxy compounds
Paul S Engel, Konstantin P Tsvaygboym, Sergei Bachilo, et al.
Antimicrobial Agents and Chemotherapy
|
September 19, 2007
Pharmacokinetics of telbivudine in subjects with various degrees of renal impairment
Xiao-Jian Zhou, Suzanne Swan, William B Smith, et al.
International Archives of Allergy and Immunology
|
January 19, 2025
Proactive Deep Learning-Facilitated Inpatient Penicillin Allergy Delabelling: An Implementation Study
Melinda Jiang, Brandon Stretton, Joshua Kovoor, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
November 26, 2024
MDMA pharmacokinetics: A population and physiologically based pharmacokinetics model-informed analysis
Marilyn A Huestis, William B Smith, Cathrine Leonowens, et al.
Journal of General Internal Medicine
|
January 23, 2021
Impact of Longitudinal Virtual Primary Care on Diabetes Quality of Care
Amy D Lu, Elise Gunzburger, Thomas J Glorioso, et al.
European Journal of Clinical Pharmacology
|
March 30, 2012
Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension
William B Smith, Thomas C Marbury, Steven F Komjathy, et al.
Antimicrobial Agents and Chemotherapy
|
April 28, 2006
Pharmacokinetics of telbivudine in subjects with various degrees of hepatic impairment
Xiao-Jian Zhou, Thomas C Marbury, Harry W Alcorn, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 17, 2013
Synthesis and HDAC inhibitory activity of isosteric thiazoline-oxazole largazole analogs
Jennifer M Guerra-Bubb, Albert A Bowers, William B Smith, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 110) with videos related to
Sort By:
Page
of 11
Journal of Clinical Pharmacology
|
January 25, 2007
Pharmacokinetics of maribavir, a novel oral anticytomegalovirus agent, in subjects with varying degrees of renal impairment
Suzanne K Swan, William B Smith, Thomas C Marbury, et al.
Journal of Clinical Pharmacology
|
October 30, 2013
A randomized, placebo-controlled study of the pharmacokinetics, pharmacodynamics, and tolerability of the oral JAK2 inhibitor fedratinib (SAR302503) in healthy volunteers
Meng Zhang, Christine R Xu, Elias Shamiyeh, et al.
The Journal of Organic Chemistry
|
March 25, 2005
Photorearrangement of alpha-azoxy ketones and triplet sensitization of azoxy compounds
Paul S Engel, Konstantin P Tsvaygboym, Sergei Bachilo, et al.
Antimicrobial Agents and Chemotherapy
|
September 19, 2007
Pharmacokinetics of telbivudine in subjects with various degrees of renal impairment
Xiao-Jian Zhou, Suzanne Swan, William B Smith, et al.
International Archives of Allergy and Immunology
|
January 19, 2025
Proactive Deep Learning-Facilitated Inpatient Penicillin Allergy Delabelling: An Implementation Study
Melinda Jiang, Brandon Stretton, Joshua Kovoor, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
November 26, 2024
MDMA pharmacokinetics: A population and physiologically based pharmacokinetics model-informed analysis
Marilyn A Huestis, William B Smith, Cathrine Leonowens, et al.
Journal of General Internal Medicine
|
January 23, 2021
Impact of Longitudinal Virtual Primary Care on Diabetes Quality of Care
Amy D Lu, Elise Gunzburger, Thomas J Glorioso, et al.
European Journal of Clinical Pharmacology
|
March 30, 2012
Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension
William B Smith, Thomas C Marbury, Steven F Komjathy, et al.
Antimicrobial Agents and Chemotherapy
|
April 28, 2006
Pharmacokinetics of telbivudine in subjects with various degrees of hepatic impairment
Xiao-Jian Zhou, Thomas C Marbury, Harry W Alcorn, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 17, 2013
Synthesis and HDAC inhibitory activity of isosteric thiazoline-oxazole largazole analogs
Jennifer M Guerra-Bubb, Albert A Bowers, William B Smith, et al.
Page
of 11